Trials / Completed
CompletedNCT00844246
Translating Evidence Based Developmental Screening Into Pediatric Primary Care
Translating Evidence Based Developmental Screening Into Pediatric Primary Care ( Aims 2 and 3 )
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 2,314 (actual)
- Sponsor
- Children's Hospital of Philadelphia · Academic / Other
- Sex
- All
- Age
- 30 Months
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to examine the feasibility, acceptability and effectiveness of implementing the American Academy of Pediatrics (AAP's) recommendation that clinicians provide developmental surveillance at all well child visits and institute developmental screening at critical developmental periods in childhood, namely at 9, 18, 24 and 30 months of age.
Detailed description
The purpose of this study is to examine the feasibility, acceptability and effectiveness of implementing the AAP's recommendation that clinicians provide developmental surveillance at all well child visits and institute developmental screening at critical developmental periods in childhood, namely at 9, 18, 24 and 30 months of age. The study will also examine its acceptance by pediatric practices, its adoption and adaptation in urban pediatric practices, and the effectiveness of a developmental screening protocol that conforms to the AAP and Maternal and Child Health Bureau (MCHB) recommendations compared with that of developmental surveillance alone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Developmental screening using ASQ and MCHAT | In the SRS intervention arm subjects will complete developmental screening tools with a school readiness specialist at their 9, 18, 24 and 30 month well child visits and then complete their well child visit with their primary care clinician to discuss the results. |
| OTHER | Developmental screening using ASQ and MCHAT | Subjects who are randomized to PCP arm will be screened for developmental delays by their Primary Care Clinician at their 9, 18, 24 and 30 month well child visits. The corresponding screening tools may be mailed to the study participants 2 weeks before the scheduled well child visits. Those who do not complete the screening tools or those who did not receive them in the mail will then complete the questionnaire in the office prior to seeing their doctor or with their doctor. The PCP will then score the screening tool and interpret the test results. Developmental counseling and/or anticipatory guidance will be provided, as per usual care. EI referral will be completed, at the discretion of the provider with the approval of the caregiver , if the subject fails the developmental screen or the caregivers raise a specific concern about the child's development. |
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2010-10-01
- Completion
- 2010-10-01
- First posted
- 2009-02-16
- Last updated
- 2011-11-10
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00844246. Inclusion in this directory is not an endorsement.